BioSpace News Archive

The global intravenous fluid bags market is growing over the years, the reason being the traditional IV bags may leak DHEP chemicals content in the fluid.

The growth of the global d-dimer testing market is ascribed to its high demand across the globe. Shortage of radiological interventions, cost effectiveness, and high accuracy is expected to bolster demand for d-dimer tests over the timeframe of analysis, from 2019 to 2029.

Seventy percent of employers have been negatively impacted by the coronavirus pandemic and more than half have implemented cost-cutting measures that affected their employees, according to Navigating the Pandemic: A Survey of U.S. Employers, a report released by nonprofit Transamerica Institute® and its Transamerica Center for Retirement Studies®.

Testing people for SARS-CoV-2 has just been made easier and more accessible with United States Food and Drug Administration emergency use authorization of the combination of SalivaDirect™ with Ubiquitome’s Liberty16 mobile real time-PCR.

Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, announced the formation of its Clinical Advisory Committee.

Third Board appointment of 2021 supports long-term vision for the company’s technology platform for 908 Devices.

Brooklyn ImmunoTherapeutics , Inc. today announced the appointment of Kevin A. D’Amour, Ph.D. as its Chief Scientific Officer.

Medidata, a Dassault Systèmes company, today launched myMedidata Registries, a new technology that expands and strengthens the myMedidata patient portal to engage patients before and after (i.e., long term follow up/safety surveillance) a clinical trial.

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem cell-based delivery of oncolytic viruses, announced today its partnership with GenScript ProBio.

EvoEndo® Inc., (“EvoEndo” or “the Company”) a preclinical medical device company developing systems for unsedated Transnasal Endoscopy (TNE), announced it has secured $10.1M in equity financing.